Prosecutors say Tesar caused referral-linked payments that Presha and Evans allegedly received after steering Medicare beneficiaries to her practice
WASHINGTON — Federal prosecutors have accused Florida registered nurses Walter Presha Junior and Koby Evans of helping direct Medicare beneficiaries toward nurse practitioner Leigh Tesar, whose Sarasota practice allegedly transformed those referrals into extraordinarily valuable wound-allograft claims.
The prosecution does not assign identical conduct to the three defendants because Tesar allegedly routed money through a Pennsylvania distributor, while Presha and Evans allegedly received separate business-account deposits tied to patients referred for federally reimbursable treatment.
The June 17, 2026, federal indictment charges all three professionals with conspiracy, but it separately charges Presha and Evans with receiving health care kickbacks and reserves the five substantive health care fraud counts for Tesar alone.
That division is essential to an accurate understanding of the case, since prosecutors cannot convict Presha or Evans merely by proving that Tesar submitted a false claim, selected an unnecessary product, or created an inaccurate medical record.
Every accusation remains unproven, and Presha, Evans, and Tesar retain the presumption of innocence unless a valid guilty plea or trial verdict establishes the elements of a charged offense beyond a reasonable doubt.
The ten-count indictment separates alleged responsibilities
Counts one through five accuse Tesar of executing or attempting to execute health care fraud through selected Medicare claims, while also invoking federal aiding-and-abetting principles for conduct allegedly performed with other known or unidentified participants.
Count six names Tesar, Presha, and Evans in an alleged conspiracy to defraud the United States, obstruct lawful Medicare administration, offer or pay referral remuneration, and solicit or receive remuneration in exchange for federally covered patient business.
Counts seven and eight address Tesar’s alleged role in causing two payments through the unnamed distributor, whereas count nine addresses Presha’s alleged receipt and count ten addresses Evans’s alleged receipt of the corresponding funds.
The charging structure therefore creates one alleged conspiracy, five claimed fraud executions, two payment offenses, and two receipt offenses, requiring jurors to evaluate different statutory elements rather than treating every allegation as a single undifferentiated scheme.
Presha and Evans face two principal theories each within the indictment: knowing participation in the broader conspiracy and knowing receipt of remuneration for referrals, together with the aiding-and-abetting provision cited alongside their substantive receipt counts.
Those theories can rely upon overlapping evidence, but a shared document, patient, product, or bank transfer does not eliminate the government’s obligation to prove each defendant’s knowledge, purpose, participation, and connection with Medicare-funded services.
The two nurses had separate business footprints
The indictment identifies Presha as a registered nurse residing in Manatee County and an owner of Universal Nursing and Wellness, while also linking him with the registered fictitious name W P Enterprises and a Wells Fargo account.
The indictment identifies Evans as a registered nurse residing in Hillsborough County and an owner of Healing His Way, a Florida limited liability company whose Bank of America account allegedly received the smaller of the two charged deposits.
Company One, the indictment’s label for an unnamed Pennsylvania distributor, allegedly marketed and sold wound-care products to Tesar and Tesar Primecare while engaging Presha, Evans, and other people as purported representatives through a fictitious business name.
Prosecutors characterize those representative agreements as shams designed to disguise patient referrals as ordinary product sales, an allegation that places the nurses’ actual services and the economic purpose of their compensation at the center of the dispute.
Written contracts and business accounts can document legitimate commercial activity, but they cannot legalize prohibited remuneration when payment actually rewards referrals, just as corporate formality alone cannot prove that apparently unusual compensation was criminal.
The defense can therefore examine training, calendars, sales records, customer contacts, product education, inventory support, expenses, tax treatment, and comparable commissions to determine whether Presha or Evans performed commercially meaningful work independent from beneficiary introductions.
Presha’s alleged timeline began during 2024
The indictment’s first overt act involving Presha concerns a June 2024 message attributed to Tesar, who allegedly discussed moving among rooms to locate wounds before acknowledging that the proposed approach could cross a legal boundary.
The charging document does not identify the facility described by that message, quote a response from Presha, or establish through the quoted fragment alone whether any particular beneficiary was found, referred, treated, or billed afterward.
Those omissions do not make the allegation irrelevant, but they give the defense room to demand the complete conversation, authentication evidence, surrounding circumstances, intended meaning, and proof connecting the exchange with later conduct attributed specifically to Presha.
In September 2024, Tesar allegedly told Presha that invoices associated with him totaled approximately $4.07 million and paired that figure with a twenty-percent calculation approaching $813,925, creating the indictment’s clearest numerical description of his anticipated compensation.
Prosecutors may argue that an invoice-based percentage measured the economic value of referred patients rather than legitimate hours, expertise, or sales work, particularly because allograft costs could expand rapidly with wound area and repeated applications.
Presha may answer that percentage commissions are common commercial arrangements and that the government must prove the calculation compensated referrals, rather than lawful product marketing, account development, education, logistics, or another service having genuine market value.
Evans entered the alleged sequence during 2025
The first overt act naming Evans occurred in January 2025, when Tesar allegedly introduced him to an owner of Company One and represented that he already knew several patients who could begin wound treatment promptly.
That introduction may support the government’s claim that beneficiary access drove the relationship, although identifying patients who might benefit from care does not itself establish that Evans demanded money, understood an unlawful arrangement, or controlled Tesar’s clinical decisions.
Later that month, Tesar allegedly explained that a new product cost $2,000 per square centimeter and that Evans would receive twenty percent of that amount instead of twenty percent calculated from a product costing $1,591.
The comparison gives prosecutors a possible link between product price and referral compensation, because a more expensive allograft could increase the financial return attributed to a purported representative without requiring additional documented work after the patient entered treatment.
Price discussions remain lawful in many health care relationships, however, so the prosecution must connect those figures with a prohibited referral purpose while the defense can identify clinical, purchasing, supply, reimbursement, or performance reasons for considering another product.
An April 2025 message attributed to Tesar allegedly warned Evans not to disclose their discussion about money, which prosecutors may present as concealment while defense counsel can challenge context, interpretation, and whether Evans accepted the asserted restriction.
One July email allegedly connected referrals with payment
The alleged accounting mechanism became more explicit in July 2025, when Tesar purportedly emailed a Company One owner information matching Primecare payments with particular products, patients, and representatives, including both Presha and Evans.
Prosecutors characterize that matching process as the financial bridge allowing the distributor to calculate and transmit referral rewards after Primecare purchased allografts associated with beneficiaries supplied by the purported representatives to Tesar’s practice.
If authenticated and interpreted as alleged, the email could link patient source, product selection, invoice value, practice payment, and representative identity in one financial record, providing a more concrete theory than suspicious billing volume alone.
The defense can still test who prepared the underlying information, whether every listed patient came from the credited representative, whether the distributor applied independent calculations, and whether payments included unrelated products, services, adjustments, or earlier obligations.
Neither an allocation spreadsheet nor the use of patient identifiers automatically establishes a kickback, because health care distributors may lawfully track accounts, inventory, commissions, product utilization, and customer-service responsibilities for legitimate operational reasons.
The decisive question is whether the records and surrounding evidence demonstrate that Presha and Evans knowingly received value in return for directing Medicare beneficiaries to services or products reimbursable through a federal health care program.
The August deposits generated four substantive counts
On August 15, 2025, Company One allegedly deposited approximately $397,570 into the W P Enterprises account associated with Presha and approximately $10,998 into the Healing His Way account associated with Evans that day.
The same transfers support four substantive counts because prosecutors accuse Tesar of causing each payment and separately accuse each recipient of accepting the corresponding deposit, illustrating how one transaction can create distinct payer and recipient theories.
Calling the transfers cash can be legally understandable because remuneration includes money, but the indictment describes bank-account deposits rather than hand-delivered currency, envelopes of banknotes, withdrawals at a meeting, or payments made directly by Presha or Evans.
That distinction corrects a potentially misleading public impression without weakening the government’s theory, since federal kickback law can reach remuneration conveyed indirectly, covertly, through intermediaries, or between formally established business accounts with recognizable documentation.
Deposits establish movement of funds if bank records authenticate them, but movement alone cannot prove why the money was sent, what each recipient understood, whether it rewarded referrals, or whether legitimate services provided an independent basis.
Prosecutors can strengthen their interpretation by aligning referrals, treatment dates, product purchases, Medicare claims, Primecare payments, distributor invoices, allocation records, communications, and deposits into a consistent chronological sequence supported by witnesses and metadata.
Defense counsel can attempt to break that sequence by showing mismatched dates, unrelated customers, genuine work, inaccurate attributions, incomplete communications, disputed calculations, or independent clinical decisions that separate compensation from federally reimbursable patient referrals.
The different payment amounts do not rank culpability
Presha’s charged deposit was more than thirty-six times larger than Evans’s charged deposit, but that numerical difference does not establish that Presha was proportionally more knowledgeable, more influential, or more culpable within the alleged conspiracy.
The figures may reflect different numbers of patients, wound sizes, products, treatment periods, invoice timing, commission calculations, account activity, or other variables that the public indictment does not fully explain and the evidence must clarify.
Likewise, Evans’s relatively smaller payment does not establish innocence, minimal involvement, or a minor legal consequence, because the receipt statute focuses on prohibited purpose and knowing conduct rather than requiring a particular monetary threshold.
The government’s forfeiture allegations seek approximately $3.19 million from Presha and approximately $263,223 from Evans as alleged proceeds, amounts substantially larger in total than the two deposits selected for their respective substantive kickback counts.
Those forfeiture figures remain contested allegations rather than findings of personal profit, program loss, restitution, or final liability, and defendants or qualifying third parties may dispute tracing, ownership, commingling, valuation, and substitute-property treatment.
Conspiracy proof must remain individualized
The conspiracy count alleges an agreement lasting from approximately May 2024 through November 2025, with objectives encompassing federal program obstruction, payment of remuneration, and receipt of remuneration connected with Medicare beneficiaries and wound-care services.
Prosecutors need not produce a document titled conspiracy agreement, because they may infer a shared purpose from coordinated communications, purported contracts, patient introductions, invoice calculations, allocation records, payments, concealment, and conduct following regulatory attention.
However, professional association, parallel conduct, or participation in the same commercial network cannot automatically establish conspiracy, since the government must prove that each nurse knowingly joined the unlawful agreement alleged by the grand jury.
The quoted overt acts are largely messages attributed to Tesar rather than statements attributed directly to Presha or Evans, making replies, acknowledgments, subsequent behavior, complete threads, and independent corroboration especially important when assessing shared intent.
A message received does not prove agreement merely because it contains suspicious language, while a payment accepted does not establish knowledge of an unlawful source unless surrounding evidence demonstrates the recipient understood the transaction’s prohibited purpose.
Conversely, prosecutors may argue that actions following the messages showed practical acceptance, particularly if patient referrals, product-linked calculations, distributor assignments, and deposits occurred consistently with the financial terms Tesar described during the charged period.
Jurors would need to consider Presha and Evans separately, because evidence that one recipient knowingly participated cannot automatically transfer to the other merely because both held nursing licenses and interacted with the same practice.
The fraud counts belong to Tesar alone
The indictment’s five health care fraud counts identify Tesar as the charged defendant and list five anonymized beneficiaries whose selected claims collectively sought approximately $3.96 million and produced approximately $2.82 million in Medicare payments.
Presha and Evans are not named as defendants in those five substantive fraud executions, although the broader narrative alleges that purported representatives helped identify beneficiaries and that Tesar acted with others known or unknown to the grand jury.
This distinction prevents an allegation about referrals from becoming an unsupported claim that either registered nurse personally authored medical notes, selected every product, submitted claims, measured wounds, performed applications, or controlled Primecare billing.
Prosecutors may nevertheless use evidence concerning allegedly false or ineligible treatment to explain why the referral stream mattered economically and why payments tied to resulting allograft business allegedly affected Medicare’s lawful administration throughout the scheme.
The defense can insist that knowledge of patient introductions or product sales does not prove knowledge of false records, nonexistent applications, infected wounds, failed conservative care, or any clinical representation later submitted by Tesar’s practice.
Evidence suggesting a particular treatment was unnecessary cannot substitute for proof that Presha or Evans knowingly accepted money for referrals, just as proof of an unlawful referral payment cannot automatically establish that every associated application never occurred.
Patient-care allegations heighten the stakes
Prosecutors allege that some allografts were used without adequate conservative treatment, placed on infected wounds, continued after nonresponse, selected for profit, or applied where terminal illness allegedly made the represented healing objective unattainable.
They separately allege that some applications billed to Medicare never occurred, a contention fundamentally different from clinical disagreement because the factual question becomes whether the represented procedure happened at all on the submitted service date.
Terminally ill patients can still require legitimate wound management addressing pain, odor, drainage, bleeding, infection, comfort, and dignity, so prognosis alone cannot establish that every treatment was unnecessary or improper under Medicare requirements.
The government’s narrower allegation concerns particular costly restorative products and the representations supporting their reimbursement, while defense experts may identify reasonable treatment objectives, partial improvement, symptom relief, uncertain prognosis, or accepted clinical judgment.
Presha’s and Evans’s potential responsibility for those circumstances depends upon admissible proof of what each nurse observed, communicated, understood, referred, or received, rather than the emotionally powerful nature of allegations involving vulnerable beneficiaries.
Beneficiaries should not be portrayed as culpable merely because they accepted professional recommendations, supplies, waived costs, gifts, or repeated treatment, since the indictment presents them principally as patients whose coverage allegedly generated commercial value.
Records can reveal whether compensation purchased referrals
Company records may show representative duties, territories, training, customer development, product support, commission formulas, invoice credit, and internal descriptions over time, helping distinguish conventional sales compensation from payments allegedly calculated around patient sourcing.
Bank records can trace money between Medicare, Primecare, the distributor, W P Enterprises, and Healing His Way, although financial tracing establishes movement and control more readily than the purpose or knowledge accompanying every transfer.
Electronic communications may explain how patients were identified, what participants understood about costs, who selected products, how representatives received credit, and whether secrecy increased after audits, delayed payments, or questions about regulatory compliance.
Clinical files and claim data can connect a referred beneficiary with wound measurements, product choice, application frequency, medical necessity, reimbursement, and eventual invoice value, allowing experts to test whether financial incentives tracked treatment intensity.
Witnesses from the practice, distributor, care facilities, beneficiary households, and related businesses may provide firsthand accounts, but prosecutors and defense lawyers must compare memories with contemporaneous records, especially when illness and repeated visits complicate recollection.
Corporate records can show ownership and banking authority, while tax returns, payroll information, expense documentation, contracts, and work products can test whether the two recipient businesses operated as enterprises or primarily collected patient-linked compensation.
No single spreadsheet, text message, contract, deposit, or statistical outlier necessarily proves the entire prosecution theory, so corroboration across professional, clinical, electronic, corporate, and financial evidence will be central to any eventual verdict after trial.
Public reporting compressed the allegations quickly
Regional reporting by WWSB summarized the indictment by explaining that Presha and Evans allegedly received kickbacks for referring patients while Tesar allegedly billed Medicare for expensive wound allografts through an eighteen-month operation in Florida.
That concise account accurately captures the prosecution’s outline, but headlines can blur the crucial distinctions between payment and receipt, electronic deposits and physical currency, referral offenses and fraud executions, or allegations and adjudicated findings.
The government says the broader operation generated more than $118 million in submitted claims, approximately $61 million in Medicare payments, and about $11.8 million in seized assets, figures that provide scale without proving either nurse’s guilt.
Seizure preserves disputed property while litigation proceeds, whereas forfeiture requires a lawful basis and remains subject to challenges involving traceability, ownership, legitimate income, valuation, commingling, and the rights of qualifying third parties under federal law.
Responsible coverage should therefore avoid describing Presha or Evans as convicted fraudsters, stating that they personally stole the aggregate Medicare figure, or treating restrained assets as money permanently awarded to the government after indictment.
The national takedown magnified professional consequences
Federal officials announced the Florida prosecution during the 2026 National Health Care Fraud Takedown, which involved 455 defendants across fifty-six federal districts and forty-five states and territories in alleged schemes exceeding $6.5 billion in claims.
Authorities said ninety physicians and other licensed professionals were included nationally and more than $182 million in assets were seized, statistics that explain enforcement intensity but do not establish any element against Presha, Evans, or Tesar.
Allegations that nurses monetized patient access can immediately affect employment, licensing, payer enrollment, banking, professional relationships, and community trust because patients depend upon nursing professionals for candid guidance during illness, uncertainty, and financial pressure.
Health care organizations can reduce comparable risk through conflict disclosures, fair-market-value reviews, referral-independent compensation, documented duties, exclusion screening, patient-cost explanations, inventory reconciliation, medical-necessity audits, and protected reporting channels for employees and contractors alike.
Those controls do not presume every commission, introduction, or product discussion is improper, but they create contemporaneous evidence explaining who performed the work, who selected the treatment, why compensation was paid, and whether patient welfare remained independent.
Unresolved accusations require disciplined communication
Organizations confronting comparable public allegations may need carefully coordinated crisis public relations management that preserves evidence, aligns verified statements with counsel, corrects demonstrable inaccuracies, respects release conditions, and avoids premature claims of guilt or vindication.
Longer-term reputation rebuilding strategies can communicate documented compliance reforms, verified professional developments, accurate court outcomes, and meaningful accountability without erasing legitimate journalism, manipulating public records, intimidating critics, or concealing material information from patients and regulators.
Nothing in the reviewed public materials indicates that Amicus International Consulting represents Presha, Evans, Tesar, Primecare, Company One, or any connected person or organization involved in the federal criminal prosecution currently pending before trial.
Later dismissals, pleas, acquittals, convictions, sentences, restitution orders, forfeiture rulings, or appellate decisions should receive prominence comparable with the initial indictment, because search results can preserve incomplete accusations long after the procedural record changes.
What prosecutors must ultimately establish
Against Presha, prosecutors must prove the charged conspiracy and the alleged receipt of approximately $397,570 with the necessary knowing and willful purpose, while connecting the disputed payment with Medicare beneficiary referrals rather than lawful representative services.
Against Evans, prosecutors must prove the same categories of criminal intent regarding the alleged $10,998 receipt, without relying upon Presha’s larger payment, Tesar’s treatment decisions, or the aggregate billing figures as substitutes for individualized evidence.
The government may present the two nurses as parallel referral sources within one financial architecture, but separate companies, communications, patients, payment amounts, knowledge, conduct, and defenses require distinct evaluation throughout motions, trial, and any verdict.
Presha and Evans may contest whether their agreements were shams, whether they referred the identified beneficiaries, whether compensation reflected legitimate work, whether Tesar retained independent clinical authority, and whether either man understood any arrangement as unlawful.
Tesar may dispute the alleged payment purpose, medical-necessity conclusions, record interpretations, claim calculations, and ownership narrative, while all three defendants can challenge the existence, scope, membership, duration, or objectives of the charged conspiracy.
Until admissible evidence proves or breaks those connections, Walter Presha Junior and Koby Evans remain defendants in a contested Medicare kickback prosecution, not adjudicated participants in the health care fraud scheme described by federal prosecutors.
